Human enterovirus species B in ileocecal Crohn's disease

Clinical and Translational Gastroenterology

Volumn 4, Issue , 2013, Pages

  Nyström, Niklas ^a   Berg, Tove ^b   Lundin, Elin ^c   Skog, Oskar ^c   Hansson, Inga ^c   Frisk, Gun ^c   Juko Pecirep, Ivana ^c   Nilsson, Mats ^c   Gyllensten, Ulf ^c   Finkel, Yigael ^b   Fuxe, Jonas ^b   Wanders, Alkwin ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ATG16L1 GENE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; CROHN DISEASE; ECHO VIRUS; ENTEROVIRUS; FEMALE; GANGLION; GENE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEOCECAL CROHN DISEASE; INTESTINE BIOPSY; INTESTINE INNERVATION; INTESTINE MUCOSA; INTESTINE SURGERY; INTESTINE VOLVULUS; MALE; NOD2 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD;

EID: 84879970484     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2013.7     Document Type: Article

References (43)

1. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19(Suppl A): 5-36.
2. Levine A, Griffiths A, Markowitz J et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011; 17: 1314-1321.
3. Sartini A, Castellani L, Buonfiglioli F et al. Update on Crohn's disease: a polymorphic entity. Minerva Gastroenterol Dietol 2011; 57: 89-96.
4. Cheli R, Dodero M, Celle G. On the histology and histopathology of the jejunal mucosa obtained by biopsy-observations and critical analysis. Gastroenterologia 1964; 102: 111-124.
5. Ferrante M, de Hertogh G, Hlavaty T et al. The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence. Gastroenterology 2006; 130: 1595-1606. (Pubitemid 43668839)
6. Ng SC, Lied GA, Kamm MA et al. Predictive value and clinical significance of myenteric plexitis in Crohn's disease. Inflamm Bowel Dis 2009; 15: 1499-1507.
7. Sokol H, Polin V, Lavergne-Slove A et al. Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut 2009; 58: 1218-1225.
8. Hubbard VM, Cadwell K. Viruses, autophagy genes, and Crohn's disease. Viruses 2011; 3: 1281-1311.
9. Naser SA, Arce M, Khaja A et al. Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis. World J Gastroenterol 2012; 18: 412-424.
10. Simmons A. Crohn's disease: genes, viruses and microbes. Nature 2010; 466: 699-700.
11. Petermann I, Huebner C, Browning BL et al. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort. Hum Immunol 2009; 70: 440-446.
12. Sabbah A, Chang TH, Harnack R et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol 2009; 10: 1073-1080.
13. Cadwell K, Patel KK, Maloney NS et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010; 141: 1135-1145.
14. Ahmad T, Satsangi J, McGovern D et al. Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther 2001; 15: 731-748. (Pubitemid 32500420)
15. Mannon PJ. Environmental triggers, genetic background, and Crohn's disease. Gastroenterology 2011; 140: 363-365.
16. Alirezaei M, Flynn CT, Wood MR et al. Pancreatic acinar cell-specific autophagy disruption reduces coxsackievirus replication and pathogenesis in vivo. Cell Host Microbe 2012; 11: 298-305.
17. Murray PJ. Beyond peptidoglycan for Nod2. Nat Immunol 2009; 10: 1053-1054.
18. Cadwell K, Liu JY, Brown SL et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008; 456: 259-263.
19. Kolho KL, Klemola P, Simonen-Tikka ML et al. Enteric viral pathogens in children with inflammatory bowel disease. J Med Virol 2012; 84: 345-347.
20. Masclee GM, Penders J, Pierik M et al. Enteropathogenic viruses: triggers for exacerbation in IBD? A prospective cohort study using real-time quantitative polymerase chain reaction. Inflamm Bowel Dis 2013; 19: 124-131.
21. Cuffari C. The genetics of inflammatory bowel disease: diagnostic and therapeutic implications. World J Pediatr 2010; 6: 203-209.
22. Economou M, Trikalinos TA, Loizou KT et al. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004; 99: 2393-2404. (Pubitemid 40039371)
23. Rhoades RE, Tabor-Godwin JM, Tsueng G et al. Enterovirus infections of the central nervous system. Virology 2011; 411: 288-305.
24. Li Y, Pan Z, Ji Y et al. Enterovirus replication in valvular tissue from patients with chronic rheumatic heart disease. Eur Heart J 2002; 23: 567-573. (Pubitemid 35192204)
25. Miao LY, Pierce C, Gray-Johnson J et al. Monoclonal antibodies to VP1 recognize a broad range of enteroviruses. J Clin Microbiol 2009; 47: 3108-3113.
26. Yazdanyar S, Kamstrup PR, Tybjaerg-Hansen A et al. Penetrance of NOD2/CARD15 genetic variants in the general population. CMAJ 2010; 182: 661-665.
27. Idestrom M, Rubio C, Granath F et al. CARD15 mutations are rare in Swedish pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2005; 40: 456-460. (Pubitemid 40489573)
28. Amre DK, Mack DR, Morgan K et al. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm Bowel Dis 2009; 15: 501-507.
29. Raschperger E, Thyberg J, Pettersson S et al. The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis. Exp Cell Res 2006; 312: 1566-1580.
30. Tomko RP, Johansson CB, Totrov M et al. Expression of the adenovirus receptor and its interaction with the fiber knob. Exp Cell Res 2000; 255: 47-55. (Pubitemid 30115287)
31. Klingel K, Hohenadl C, Canu A et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 1992; 89: 314-318.
32. Feuer R, Mena I, Pagarigan RR et al. Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency. Med Microbiol Immunol 2004; 193: 83-90. (Pubitemid 38703775)
33. Chapman NM, Kim KS. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 2008; 323: 275-292.
34. Tam PE, Messner RP. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 1999; 73: 10113- 10121.
35. Feuer R, Ruller CM, An N et al. Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J Virol 2009; 83: 9356-9369.
36. Hollander D. Intestinal permeability in patients with Crohn's disease and their relatives. Dig Liver Dis 2001; 33: 649-651. (Pubitemid 33107661)
37. Edelblum KL, Turner Jr. The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol 2009; 9: 715-720.
38. Schulzke JD, Ploeger S, Amasheh M et al. Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci 2009; 1165: 294-300.
39. Martino TA, Petric M, Weingartl H et al. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 2000; 271: 99-108. (Pubitemid 30341519)
40. Coyne CB, Bergelson JM. CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 2005; 57: 869-882. (Pubitemid 40488108)
41. Walters RW, Freimuth P, Moninger TO et al. Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 2002; 110: 789-799. (Pubitemid 35283966)
42. Kellow JE. Myenteric plexitis in enteric dysmotility: what are the implications for clinical practice? Gut 2009; 58: 1042-1043.
43. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683-1699. (Pubitemid 26404236)